This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The analysis of the clinical study appears to have been conducted on the basis of treatment completers only. However, the analysis was repeated under the assumption that all participants with missing data did badly at the 12-month followup. The outcome measures used were: the number of drinks per drinking day; the total number of days abstinent; the total number of alcohol units consumed;
the time to first drink; the reduction in alcohol-related problems; social satisfaction; self-esteem; abstinence or moderate drinking; and severity of dependence.
The number-needed-to-treat (NNT) to produce one extra non-drinker was also calculated.
At study entry, the groups were comparable on any pre-treatment variable.
Effectiveness results
The number of drinks per drinking day was significantly lower in the intervention group at 3 months (p=0.012) and 12 months, (p=0.005), (the results were not reported).
The total number of days abstinent in the 90-day period prior to assessment was significantly higher in the intervention group, (p=0.004), (the results were not reported).
The total number of alcohol units consumed in the 90-day period prior to assessment was significantly lower in the intervention group, (p=0.002), (the results were not reported).
The time to first drink was 114 days in the intervention group and 52 days in the control group, (p=0.011).
A significant reduction in alcohol-related problems was observed in the intervention group in comparison with the control group, (p=0.048), (the results were not reported).
Significantly better social satisfaction was observed in the intervention group in comparison with the control group at both 3 and 12 months, (p=0.02), (the results were not reported).
There was a trend towards improvements in self-esteem in the intervention group in comparison with the control group, (p=0.061), (the results were not reported).
With respect to abstinence or moderate drinking, at the 3-month follow-up, the number of participants abstinent or drinking 3 or fewer units a day was 10 in the control group and 25 in the intervention group. The numbers of participants drinking more than 3 units a day were 32 (control group) and 18 (intervention group), respectively.
At the 12-month follow-up, the number of participants abstinent or drinking 3 or fewer units a day was 3 in the control group and 15 in the intervention group. The numbers of participants drinking more than 3 units a day were 37 (control group) and 23 (intervention group), respectively. Thus, 39.47% of patients in the intervention group versus 7.5% in the control group were abstinent or drank less than 3 units per drinking day. This difference (31.97%) reached statistical significance.
The NNT to produce one extra non-drinker was 3.13 (32/100).
Severity of dependence was comparable between the groups.
Clinical conclusions
The effectiveness analysis showed that a PI added to a home detoxification programme was more effective than a home detoxification programme alone in increasing abstinence days and improving other aspects of care.
Measure of benefits used in the economic analysis
The health outcomes were left disaggregated and no summary benefit measure was used in the economic analysis. In effect, a cost-consequences analysis was performed.
Direct costs
The analysis of costs compared the detoxification programme plus the PI with both an inpatient and an outpatient detoxification programme. Discounting was not relevant since the costs were incurred during one year. The unit costs were presented separately from the quantities of resources used. The health services included in the economic evaluation were inpatient stay, outpatient visits, home visits and detoxification medications. The cost/resource boundary of the NHS was used. The costs were estimated, based on the treatment of a hypothetical patient. The unit costs were derived from both local sources and national prices. The resource use data was based on typical treatment patterns. The price year was not explicitly stated, but most of the costs were estimated for 2001.
